Mutations involved in the spliceosome complex (SF3B1, SRSF2, U2AF1), which are commonly mutated in MDS patients, were significantly enriched in population-based individuals with thrombocytopenia.34,35 Similarly, spliceosome mutations were enriched in older individuals with anemia compared with matched controls.7 However, the enrichment of spliceosome mutations in thrombocytopenia cases could not be explained by the presence of additional cytopenias, for instance anemia. This evidence concerns the gene SF3B1 and myelodysplastic syndrome.